What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Pharmacology
- Endocrinology
David J. Greenblatt spends much of his time researching Pharmacology, Pharmacokinetics, Internal medicine, Endocrinology and Anesthesia.
His work on Drug interaction as part of general Pharmacology research is often related to Ketoconazole, thus linking different fields of science.
His Pharmacokinetics study which covers Alprazolam that intersects with Triazolam.
The various areas that he examines in his Anesthesia study include Placebo, Drug and Insomnia.
As part of one scientific family, he deals mainly with the area of Volume of distribution, narrowing it down to issues related to the Distribution, and often Acetaminophen.
His studies in Benzodiazepine integrate themes in fields like Hypnotic, Lorazepam, Sedation and Agonist.
His most cited work include:
- A method for estimating the probability of adverse drug reactions (7235 citations)
- Midazolam: pharmacology and uses. (808 citations)
- Drug Disposition in Old Age (515 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Pharmacology, Pharmacokinetics, Anesthesia, Internal medicine and Endocrinology.
His Pharmacology study combines topics in areas such as Microsome, Lorazepam and Benzodiazepine.
His Pharmacokinetics study integrates concerns from other disciplines, such as Oral administration and Crossover study.
The concepts of his Anesthesia study are interwoven with issues in Discontinuation, Placebo and Triazolam.
His research in Internal medicine is mostly concerned with Free fraction.
His research on Endocrinology often connects related areas such as In vivo.
He most often published in these fields:
- Pharmacology (52.18%)
- Pharmacokinetics (35.96%)
- Anesthesia (24.32%)
What were the highlights of his more recent work (between 2005-2021)?
- Pharmacology (52.18%)
- Pharmacokinetics (35.96%)
- Internal medicine (26.80%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Pharmacology, Pharmacokinetics, Internal medicine, CYP3A and Anesthesia.
His study of Drug is a part of Pharmacology.
His Pharmacokinetics research is multidisciplinary, relying on both Sedation, Zolpidem and Placebo, Crossover study.
David J. Greenblatt interconnects Gastroenterology and Endocrinology in the investigation of issues within Internal medicine.
His research integrates issues of Cytochrome P-450 CYP3A, Hydroxylation, Triazolam and Grapefruit juice in his study of CYP3A.
He has researched Microsome in several fields, including IC50 and Cytochrome P450.
Between 2005 and 2021, his most popular works were:
- Effect of Obesity on the Pharmacokinetics of Drugs in Humans (476 citations)
- Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly (154 citations)
- Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly (154 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Pharmacology
- Enzyme
David J. Greenblatt focuses on Pharmacology, Pharmacokinetics, CYP3A, Internal medicine and Pharmacodynamics.
His study in Pharmacology is interdisciplinary in nature, drawing from both Metabolite and Ritonavir.
The Pharmacokinetics study combines topics in areas such as Zolpidem, Hypnotic, Anesthesia, Crossover study and Bioavailability.
His CYP3A study combines topics from a wide range of disciplines, such as Midazolam, Cytochrome P-450 CYP3A and Triazolam.
His Internal medicine research incorporates themes from Gastroenterology, Endocrinology and Oncology.
His studies in Pharmacodynamics integrate themes in fields like Psychiatry, Pharmacotherapy, Cmax and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
